A Pilot Study Evaluating a Novel Biodynamic Imaging (BDI) Method in Predicating Response to Chemotherapy in Locoregional Esophageal Cancer
Shadia Jalal, MD
Primary Investigator
Brief description of study
Researchers would like to determine if a new imaging technique called Biodynamic Imagining (BDI) is appropriate for clinical use in the treatment of esophageal cancer. The purpose of this study is to determine if the tumor tissue can be collected, transported and successfully processed using BDI technology.
Detailed description of study
Researchers would like to determine if a new imaging technique called Biodynamic Imagining (BDI) is appropriate for clinical use in the treatment of esophageal cancer. The purpose of this study is to determine if the tumor tissue can be collected, transported and successfully processed using BDI technology.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: esophageal cancer
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria
Histologically confirmed adenocarcinoma of the esophagus
Must have a TNM stag I-III disease and no evidence of distant metastasis
Previously untreated for esophageal cancer
Must be medically fit and willing to receive chemoradiation therapy for their disease
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
